相关实验视频

Updated: May 15, 2025

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Published on: May 6, 2019

缺乏ATM的癌症的寒冷免疫学景观

Sonali Sinha¹, Victor Ng¹, Ardijana Novaj¹

¹Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Journal for immunotherapy of cancer

|May 11, 2025

概括

形电脉切开症突变 (ATM) 损失不会增强瘤免疫性,即使使用了破坏DNA的药物. ATM 缺陷会影响DNA 修复,但不能增加免疫细胞透或瘤中的抗原性.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
遗传学是一个遗传学.

背景情况:

在DNA修复基因的突变可以增加瘤免疫性.
突变的telangiectasia (ATM) 是DNA双链断裂修复的关键,并且在癌症中经常发生突变.
ATM损失对瘤免疫力的影响尚不清楚.

研究的目的:

研究ATM损失对瘤免疫性和对治疗的反应的影响.
探索ATM缺乏对免疫细胞透和瘤微环境的影响.
评估DNA损伤剂对ATM-null瘤和免疫信号的影响.

主要方法:

使用CRISPR生成了ATM-null小鼠癌症模型 (4T1,CT26).
通过流细胞计和免疫组织化学在小鼠和人类样本中评估免疫细胞透.
在体内评估瘤生长,对抗PD-1阻断的反应,以及ATR抑制剂,PARP抑制剂和埃托对ISG表达的作用.

主要成果:

由于ATM缺乏,免疫细胞的透率并没有增加,也没有通过合成致死性 (例如ATR抑制) 进行招募.
埃托波西德是一种拓酶II抑制剂,在ATM-null瘤中强烈激活了I型干扰素 (IFN) 信号.
在ATM-null模型中,抗PD-1疗法没有提高埃托波的疗效,也没有改变瘤微环境,这表明免疫激活不足.

结论:

瘤抗原酶缺乏会损害DNA修复,增加对辐射和ATR抑制的敏感性,但不会增强瘤抗原性或免疫性.
失去ATM会导致免疫学上"冷"的瘤,不会对当前的免疫检查点封锁策略做出反应.
这些发现强调了抗原性在DNA修复缺陷的免疫学结果中的关键作用,并为ATM-null癌症的新型组合疗法设计提供了信息.

关键词:

免疫检查点抑制剂免疫检查点抑制剂免疫治疗是一种免疫疗法.这是天生的,天生的.瘤突变负担 - - 瘤突变负担

更多相关视频

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8⁺ T Cells During LN Metastasis

Published on: January 26, 2024

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

相关概念视频

Cell-mediated Immune Responses

Cell-mediated Immune Responses

Immunodeficiency Diseases

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.